Avenue Therapeutics Files 8-K
Ticker: ATXI · Form: 8-K · Filed: Mar 7, 2025 · CIK: 1644963
Sentiment: neutral
Topics: corporate-filing, 8-k
Related Tickers: AVTX
TL;DR
AVTX filed an 8-K on 3/7/25. Standard corporate update.
AI Summary
Avenue Therapeutics, Inc. filed an 8-K on March 7, 2025, reporting other events and financial statements. The company is incorporated in Delaware and its principal executive offices are located in Bay Harbor Islands, Florida.
Why It Matters
This filing provides an update on Avenue Therapeutics' corporate activities and financial reporting, which is important for investors to monitor the company's status.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for corporate information and does not appear to contain significant new material events.
Key Players & Entities
- Avenue Therapeutics, Inc. (company) — Registrant
- March 7, 2025 (date) — Filing Date
- Delaware (jurisdiction) — State of Incorporation
- Bay Harbor Islands, FL (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Avenue Therapeutics, Inc.?
The filing is a Current Report (Form 8-K) pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting 'Other Events' and 'Financial Statements and Exhibits'.
When was this 8-K report filed?
The report was filed on March 7, 2025.
In which state is Avenue Therapeutics, Inc. incorporated?
Avenue Therapeutics, Inc. is incorporated in Delaware.
What is the address of Avenue Therapeutics, Inc.'s principal executive offices?
The principal executive offices are located at 1111 Kane Concourse, Suite 301, Bay Harbor Islands, FL 33154.
What is the telephone number for Avenue Therapeutics, Inc.?
The registrant's telephone number, including area code, is (781) 652-4500.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 7, 2025 regarding AVENUE THERAPEUTICS, INC. (ATXI).